ArticleDiscover oncology2024
New direction: identification of immunoinflammatory subtypes and potential therapeutic targets for cholangiocarcinoma.
Zhixuan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it